Aptevo Therapeutics Receives $4.3 Million Milestone Payment From Saol International Limited

NEXT STORY
BioAegis Therapeutics Reports Favorable Safety and Pharmacokinetic Results in its Phase 1b/2a Dose-Escalation Study of Recombinant Human Plasma Gelsolin with Highest Doses Ever Administered to Patients
PREV STORY
New York Psychiatrist, Dr. Aleksandra Krunic, Introduces Groundbreaking FDA-Cleared Helmet to Treat Obsessive-Compulsive Disorder (OCD)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TG Therapeutics, Inc. Announces Advancement of its Anti-PD-L1 Monoclonal Antibody into Clinical Development

NEW YORK, Oct. 05, 2017 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDQ:TGTX), today announced ...

author_avatar
NASDAQ Market News

Kura Oncology Reports Second Quarter 2020 Financial Results

author_avatar
NASDAQ Market News

Tiziana Life Sciences PLC (“Tiziana” or “the Company”) – Notification of proposed admission to the Main Market and cancellation of trading on AIM

author_avatar
NASDAQ Market News